Sio Capital Management, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Sio Capital Management, LLC disclosed 38 US equity positions worth $223.2m in its Q3 2024 13F filing. The largest position was LH at 17.4% of the reported book, followed by TEVA and MMS.
What did Sio Capital Management, LLC own in Q3 2024? Top 38 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | LH LABCORP HOLDINGS INC | Healthcare | 17.4% | $38.7m | 173,293 | – | |
| 2 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Healthcare | 10.9% | $24.3m | 1,349,274 | – | |
| 3 | MMS MAXIMUS INC | Industrials | 6.5% | $14.5m | 155,142 | – | |
| 4 | ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 6.2% | $13.8m | 127,511 | – | |
| 5 | VXRT VAXART INC | 5.2% | $11.6m | 13,608,244 | – | ||
| 6 | KVUE KENVUE INC | Consumer Defensive | 4.9% | $11.0m | 474,741 | – | |
| 7 | TFX TELEFLEX INCORPORATED | Healthcare | 4.4% | $9.7m | 39,272 | – | |
| 8 | TYRA TYRA BIOSCIENCES INC | Healthcare | 4.2% | $9.4m | 400,870 | – | |
| 9 | IRON DISC MEDICINE INC | Healthcare | 4.1% | $9.2m | 187,941 | – | |
| 10 | CI THE CIGNA GROUP | Healthcare | 4.1% | $9.2m | 26,503 | – | |
| 11 | ANNX ANNEXON INC | Healthcare | 3.8% | $8.5m | 1,433,155 | – | |
| 12 | BDSX BIODESIX INC | 3.5% | $7.7m | 4,338,514 | – | ||
| 13 | RLAY RELAY THERAPEUTICS INC | Healthcare | 3.0% | $6.7m | 945,839 | – | |
| 14 | ERAS ERASCA INC | Healthcare | 2.7% | $6.1m | 2,219,186 | – | |
| 15 | CMPS COMPASS PATHWAYS PLC | Healthcare | 2.6% | $5.8m | 914,639 | – | |
| 16 | CATBUSD ASTRIA THERAPEUTICS INC | 2.5% | $5.6m | 504,887 | – | ||
| 17 | PMVP PMV PHARMACEUTICALS INC | 2.1% | $4.8m | 3,214,239 | – | ||
| 18 | VTYXUSD VENTYX BIOSCIENCES INC | 1.9% | $4.3m | 1,971,948 | – | ||
| 19 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 1.7% | $3.9m | 123,000 | – | |
| 20 | AORT ARTIVION INC | Healthcare | 1.4% | $3.2m | 121,178 | – | |
| 21 | CRGX CARGO THERAPEUTICS INC | 1.4% | $3.2m | 173,860 | – | ||
| 22 | CNTX CONTEXT THERAPEUTICS INC | 1.2% | $2.6m | 1,328,352 | – | ||
| 23 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.8% | $1.8m | 177,004 | – | |
| 24 | NUVB NUVATION BIO INC | Healthcare | 0.7% | $1.5m | 668,115 | – | |
| 25 | FHTX FOGHORN THERAPEUTICS INC. | Healthcare | 0.5% | $1.1m | 121,672 | – | |
| 26 | XFOR X4 PHARMACEUTICALS INC | 0.4% | $872.4k | 1,303,508 | – | ||
| 27 | APRE APREA THERAPEUTICS INC | 0.3% | $760.7k | 276,603 | – | ||
| 28 | AVTX AVALO THERAPEUTICS INC | Healthcare | 0.3% | $678.9k | 71,458 | – | |
| 29 | RAPT THERAPEUTICS INC | 0.3% | $633.1k | 315,000 | – | ||
| 30 | BOLD BOUNDLESS BIO INC | 0.3% | $562.3k | 162,058 | – | ||
| 31 | NYXOAH SA | 0.2% | $485.5k | 50,839 | – | ||
| 32 | VSTM VERASTEM INC | Healthcare | 0.2% | $398.9k | 133,412 | – | |
| 33 | MODULAR MED INC | 0.1% | $271.7k | 120,772 | – | ||
| 34 | NXTC NEXTCURE INC | 0.1% | $178.1k | 130,000 | – | ||
| 35 | HUMACYTE INC | 0.0% | $89.0k | 49,998 | – | ||
| 36 | 430 TERNS PHARMACEUTICALS INC | 0.0% | $83.4k | 10,000 | – | ||
| 37 | ROCKET PHARMACEUTICALS INC | 0.0% | $28.9k | 400,000 | – | ||
| 38 | CAREMAX INC | 0.0% | $108 | 12,808 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.